Brief: Kinnate Biopharma Posts Q3 Loss Per Share Of $24.7
10/11/2021 22:09
Nov 10 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS
* KINNATE BIOPHARMA INC - Q3 NET LOSS FOR 2021 WAS $24.7
MILLION,
COMPARED TO $10.5 MILLION FOR SAME PERIOD IN 2020
Source text for Eikon: ID:nGNX8YB6Lw
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview